Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Expert committee holds first meeting to examine WHO claims on Maiden Pharma case

Ruchika Sharma15 Oct 2022 2:30 PM IST

As per the tentative results of WHO's evaluation, out of the 23 samples of the products under reference were tested, of which four were found to...

Novartis Loses India Patent on Heart Failure Drug Vymada

US Supreme Court turns down Novartis bid to block launch of multiple sclerosis drug Gilenya generics

Ruchika Sharma15 Oct 2022 1:30 PM IST

Novartis settled with some of the drugmakers it had sued, allowing for some Gilenya generics before a key patent's 2027 expiration.

Abbott to Conduct BE Study for Carbimazole 15 mg, Trial Waiver Granted In India

Abbott recalls some ready-to-feed baby formula liquid products including Similac

Ruchika Sharma15 Oct 2022 12:15 PM IST

New Delhi: Abbott Laboratories said on Friday it was recalling some ready-to-feed baby formula liquid products including Similac-branded items...

India AI-powered integrated digital health gateway ekincare raises investment from MSD IDEA Studio Asia Pacific

Vaccine maker Bharat Biotech evinces interest to invest in Karnataka

Ruchika Sharma15 Oct 2022 11:20 AM IST

"There is an intention to invest in Karnataka, where the industrial environment is favourable for business," said Dr. Ella.

Rajasthan Health Dept debunks cough syrup death rumours

Child deaths linked to cough syrup have risen to 70, says Gambia

Ruchika Sharma15 Oct 2022 10:00 AM IST

Banjul: Gambia's government on Friday said the number of child deaths from acute kidney injury, thought to be linked to Indian-made cough syrups, has...

Caplin Steriles Secures USFDA Approval for Generic Methylprednisolone Injection

Unichem Labs bags USFDA nod for Extended Phenytoin Sodium Capsules

Ruchika Sharma14 Oct 2022 3:30 PM IST

Mumbai: Unichem Laboratories Limited has announced that the company has received abbreviated new drug application (ANDA) approval for its...

Gilead Sciences Trodelvy under USFDA priority review for adult patients with pretreated metastatic breast cancer

Ruchika Sharma14 Oct 2022 2:30 PM IST

Trodelvy (sacituzumab govitecan-hziy) is a first-in-class Trop-2 directed antibody-drug conjugate.

Himachal Pradesh: PM Modi lays foundation stone of Una Bulk Drug Park

Ruchika Sharma14 Oct 2022 1:30 PM IST

The Prime Minister pointed out that now that raw materials for medicine manufacturing will be produced in Himachal Pradesh, India's dependency on the...

Biological E Corbevax offers better immunity as heterologous booster shot

Ruchika Sharma14 Oct 2022 12:30 PM IST

CORBEVAX can be administered as a booster six months after two doses of COVAXIN or COVISHIELD for all adults.

Piramal Pharma gets 4 USFDA observations for Lexington facility

Piramal Pharma gets SEBI nod to list shares on Indian stock exchanges

Ruchika Sharma14 Oct 2022 11:15 AM IST

The demerger from PEL will firmly empower PPL to be future-ready and enable it to independently pursue its growth strategies with sharper focus and...

Pfizer gets USFDA Emergency Use Authorization for bivalent omicron booster in children aged 5 through 11 years

Ruchika Sharma13 Oct 2022 4:00 PM IST

New York: Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (USFDA) has granted Emergency Use Authorization...

Rising pollution, rising patients: Delhis Lok Nayak Hospital runs short of respiratory drugs

USFDA warns of Teva Pharma ADHD drug Adderall shortage

Ruchika Sharma13 Oct 2022 1:30 PM IST

Adderall is an FDA-approved prescription drug made of two stimulants amphetamine and dextroamphetamine.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok